Neil Palmer will be presenting at the conference on the following topic: Implications of Global Trends on Pharmaceutical Pricing and Reimbursement in Canada

• Value Based Assessments (UK) and AMNOG reforms (Germany) – implications for pricing in Europe and Canada
• Implications of international price referencing
• Risk sharing, listing agreements vs. increasing demands for price transparency
• Evolution of HTA in Europe and outlook for the QALY
• Formal and informal cooperation between HTA agencies: Harmonization or collusion?
• Implications of the Canada – EU Trade Agreement (CETA)
• Outlook and Implications for Canadian P&R in the global context